Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: A prospective cohort study, systematic review and individual patient data meta-analysis

Critical Care

Volumn 18, Issue 2, 2014, Pages

  Pfister, Roman ^a   Kochanek, Matthias ^a   Leygeber, Timo ^a   Brun Buisson, Christian ^b   Cuquemelle, Elise ^b   Machado, Mariana Benevides P ^c   Piacentini, Enrique ^d   Hammond, Naomi E ^e,f   Ingram, Paul R ^g,h   Michels, Guido ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d HOSPITAL MÚTUA DE TERRASSA   (Spain)

^e ROYAL NORTH SHORE HOSPITAL   (Australia)

^f GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^g ROYAL PERTH HOSPITAL   (Australia)

^h UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROCALCITONIN; CALCITONIN; PROTEIN PRECURSOR;

2009 H1N1 INFLUENZA; ADULT; ARTICLE; BACTERIAL PNEUMONIA; CLINICAL ARTICLE; COHORT ANALYSIS; CRITICALLY ILL PATIENT; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; IMMUNOCOMPROMISED PATIENT; MALE; MIDDLE AGED; MIXED INFECTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; AGED; BLOOD; CRITICAL ILLNESS; CROSS INFECTION; INFLUENZA VIRUS A H1N1; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; META ANALYSIS; PANDEMIC; PNEUMONIA, BACTERIAL; RETROSPECTIVE STUDY;

ADULT; AGED; CALCITONIN; COHORT STUDIES; CRITICAL ILLNESS; CROSS INFECTION; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PANDEMICS; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; RETROSPECTIVE STUDIES;

EID: 84897458979     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13760     Document Type: Article

References (34)

1. Dawood FS, Iuliano AD, Reed C, Meltzer MI, Shay DK, Cheng PY, Bandaranayake D, Breiman RF, Brooks WA, Buchy P, Feikin DR, Fowler KB, Gordon A, Hien NT, Horby P, Huang QS, Katz MA, Krishnan A, Lal R, Montgomery JM, Mølbak K, Pebody R, Presanis AM, Razuri H, Steens A, Tinoco YO, Wallinga J, Yu H, Vong S, Bresee J, Widdowson MA, et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis 2012, 12:687-695. A published erratum appears in Lancet Infect Dis 2012, 12:655, 10.1016/S1473-3099(12)70121-4, 22738893.
2. Cao B, Li XW, Mao Y, Wang J, Lu HZ, Chen YS, Liang ZA, Liang L, Zhang SJ, Zhang B, Gu L, Lu LH, Wang DY, Wang C, National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med 2009, 361:2507-2517. 10.1056/NEJMoa0906612, 20007555, National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China.
3. Domínguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, Poblano-Morales M, Baltazar-Torres JA, Bautista E, Martinez A, Martinez MA, Rivero E, Valdez R, Ruiz-Palacios G, Hernández M, Stewart TE, Fowler RA. Critically ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009, 302:1880-1887. 10.1001/jama.2009.1536, 19822626.
4. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, Sugerman DE, Druckenmiller JK, Ritger KA, Chugh R, Jasuja S, Deutscher M, Chen S, Walker JD, Duchin JS, Lett S, Soliva S, Wells EV, Swerdlow D, Uyeki TM, Fiore AE, Olsen SJ, Fry AM, Bridges CB, Finelli L, Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009, 2009:1935-1944. Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team.
5. Rello J, Rodríguez A, Ibañez P, Socias L, Cebrian J, Marques A, Guerrero J, Ruiz-Santana S, Marquez E, Del Nogal-Saez F, Alvarez-Lerma F, Martínez S, Ferrer M, Avellanas M, Granada R, Maraví-Poma E, Albert P, Sierra R, Vidaur L, Ortiz P, Prieto Del Portillo I, Galván B, León-Gil C, H1N1 SEMICYUC Working Group Intensive care adult patients with severe respiratory failure caused by influenza A (H1N1)v in Spain. Crit Care 2009, 13:R148. 10.1186/cc8044, 2784367, 19747383, H1N1 SEMICYUC Working Group.
6. Rice TW, Rubinson L, Uyeki TM, Vaughn FL, John BB, Miller RR, Higgs E, Randolph AG, Smoot BE, Thompson BT, the NHLBI ARDS Network Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit Care Med 2012, 40:1487-1498. 10.1097/CCM.0b013e3182416f23, 3653183, 22511131, the NHLBI ARDS Network.
7. Webb SAR, Pettilä V, Seppelt I, Bellomo R, Bailey M, Cooper DJ, Cretikos M, Davies AR, Finfer S, Harrigan PWJ, Hart GK, Howe B, Iredell JR, McArthur C, Mitchell I, Morrison S, Nichol AD, Paterson DL, Peake S, Richards B, Stephens D, Turner A, Yung M, the Australian and New Zealand Intensive Care (ANZIC) Influenza Investigators Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009, 361:1925-1934. the Australian and New Zealand Intensive Care (ANZIC) Influenza Investigators.
8. Houck PM, Bratzler DW, Nsa W, Ma A, Bartlett JG. Antibiotic administration in community-acquired pneumonia. Chest 2004, 126:320-321. 10.1378/chest.126.1.320, 15249486.
9. Niederman MS. Biological markers to determine eligibility in trials for community-acquired pneumonia: a focus on procalcitonin. Clin Infect Dis 2008, 47:S127-S132. 10.1086/591393, 18986278.
10. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004, 39:206-217. 10.1086/421997, 15307030.
11. Boussekey N, Leroy O, Georges H, Devos P, d'Escrivan T, Guery B. Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit. Infection 2005, 33:257-263. 10.1007/s15010-005-4096-2, 16091896.
12. Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis 2013, 13:426-435. 10.1016/S1473-3099(12)70323-7, 23375419.
13. Christ-Crain M, Stolz D, Bingisser R, Müller C, Miedinger D, Huber PR, Zimmerli W, Harbarth S, Tamm M, Müller B. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 2006, 174:84-93. 10.1164/rccm.200512-1922OC, 16603606.
14. Schuetz P, Chiappa V, Briel M, Greenwald JL. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med 2011, 171:1322-1331. 10.1001/archinternmed.2011.318, 21824946.
15. Nobre V, Harbarth S, Graf JD, Rohner P, Pugin J. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 2008, 177:498-505. 10.1164/rccm.200708-1238OC, 18096708.
16. Cuquemelle E, Soulis F, Villers D, Roche-Campo F, Ara Somohano C, Fartoukh M, Kouatchet A, Mourvillier B, Dellamonica J, Picard W, Schmidt M, Boulain T, Brun-Buisson C, A/H1N1 REVA-SRLF Study Group Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study. Intensive Care Med 2011, 37:796-800. 10.1007/s00134-011-2189-1, 21369807, A/H1N1 REVA-SRLF Study Group.
17. Hammond NE, Corley A, Fraser JF. The utility of procalcitonin in diagnosis of H1N1 influenza in intensive care patients. Anaesth Intensive Care 2011, 39:238-241.
18. Ingram PR, Inglis T, Moxon D, Speers D. Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection. Intensive Care 2010, 36:528-532.
19. Paiva MBS, Botoni FA, Teixeira AL, de Miranda AS, de Oliveira CR, de Oliveira Abrahão J, Faria GM, Nobre V. The behavior and diagnostic utility of procalcitonin and five other inflammatory molecules in critically ill patients with respiratory distress and suspected 2009 influenza A H1N1 infection. Clinics (Sao Paulo) 2012, 67:327-334. 10.6061/clinics/2012(04)05, 3317251, 22522757.
20. Piacentini E, Sánchez B, Arauzo V, Calbo E, Cuchi E, Nava JM. Procalcitonin levels are lower in intensive care unit patients with H1N1 influenza A virus pneumonia than in those with community-acquired bacterial pneumonia: a pilot study. J Crit Care 2011, 26:201-205. 10.1016/j.jcrc.2010.07.009, 20813489.
21. Almansa R, Bermejo-Martín JF, Ortiz de Lejarazu Leonardo R. [Immunopathogenesis of 2009 pandemic influenza] [in Spanish]. Enferm Infecc Microbiol Clin 2012, 30:18-24.
22. Lee N, Wong CK, Chan PKS, Chan MCW, Wong RYK, Lun SWM, Ngai KLK, Lui GCY, Wong BCK, Lee SKW, Choi KW, Hui DSC. Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults. PLoS One 2011, 6:e26050. 10.1371/journal.pone.0026050, 3192778, 22022504.
23. Moher D, Liberati A, Tetzlaff J, Altman DG, the PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009, 6:e1000097. 10.1371/journal.pmed.1000097, 2707599, 19621072, the PRISMA Group.
24. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV, Xu X, Bridges CB, Uyeki TM, the Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009, 360:2605-2615. A published erratum appears in N Engl J Med 2009, 361:102, the Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team.
25. Wu MH, Lin CC, Huang SL, Shih HM, Wang CC, Lee CC, Wu JY. Can procalcitonin tests aid in identifying bacterial infections associated with influenza pneumonia? A systematic review and meta-analysis. Influenza Other Respir Viruses 2013, 7:349-355. 10.1111/j.1750-2659.2012.00386.x, 22672284.
26. Persson L, Söderquist B, Engervall P, Vikerfors T, Hansson LO, Tidefelt U. Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia. Eur J Haematol 2005, 74:297-303. 10.1111/j.1600-0609.2004.00387.x, 15777341.
27. Dallas J, Brown SM, Hock K, Scott MG, Skrupky LP, Boyle WA, Kollef MH. Diagnostic utility of plasma procalcitonin for nosocomial pneumonia in the intensive care unit setting. Respir Care 2011, 56:412-419. 10.4187/respcare.00979, 21255510.
28. Luyt CE, Combes A, Reynaud C, Hekimian G, Nieszkowska A, Tonnellier M, Aubry A, Trouillet JL, Bernard M, Chastre J. Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med 2008, 34:1434-1440. 10.1007/s00134-008-1112-x, 18421435.
29. Schuetz P, Albrich W, Christ-Crain M, Chastre J, Mueller B. Procalcitonin for guidance of antibiotic therapy. Expert Rev Anti Infect Ther 2010, 8:575-587. 10.1586/eri.10.25, 20455686.
30. Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med 2011, 9:107. 10.1186/1741-7015-9-107, 3186747, 21936959.
31. Schuetz P, Amin DN, Greenwald JL. Role of procalcitonin in managing adult patients with respiratory tract infections. Chest 2012, 141:1063-1073. 10.1378/chest.11-2430, 22474148.
32. Lentino JR, Lucks DA. Nonvalue of sputum culture in the management of lower respiratory tract infections. J Clin Microbiol 1987, 25:758-762. 266084, 2438299.
33. Waterer GW, Wunderink RG. The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures. Respir Med 2001, 95:78-82. 10.1053/rmed.2000.0977, 11207022.
34. Bewick T, Myles P, Greenwood S, Nguyen-Van-Tam JS, Brett SJ, Semple MG, Openshaw PJ, Bannister B, Read RC, Taylor BL, McMenamin J, Enstone JE, Nicholson KG, Lim WS, the Influenza Clinical Information Network (FLU-CIN) Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults. Thorax 2011, 66:247-252. 10.1136/thx.2010.151522, 3047189, 21252388, the Influenza Clinical Information Network (FLU-CIN).